# Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7)

> **NCT03475459** · PHASE1 · COMPLETED · sponsor: **Nobelpharma** · enrollment: 12 (actual)

## Conditions studied

- Qt Interval, Variation in

## Interventions

- **DRUG:** NPC-15 and/or Placebo

## Key facts

- **NCT ID:** NCT03475459
- **Lead sponsor:** Nobelpharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-03
- **Primary completion:** 2018-04-29
- **Final completion:** 2018-04-29
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03475459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03475459, "Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03475459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*